Evidence map›Paper›PMID 35254466›Full record

ArticleDer Nervenarzt2023

[Essen transition model for neuromuscular diseases].

Michael Fleischer, Bayram Coskun, Benjamin Stolte, Adela Della-Marina, Heike Kölbel, Hildegard Lax, Michael Nonnemacher, Christoph Kleinschnitz, Ulrike Schara-Schmidt, Tim Hagenacker

Open access · hybridAbstract readEnglish Abstract
In one paragraph

Article in Der Nervenarzt, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Michael FleischerKlinik für Neurologie und Center for Translational Neuro- and Behavioral Science, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Bayram CoskunKlinik für Neurologie und Center for Translational Neuro- and Behavioral Science, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Benjamin StolteKlinik für Neurologie und Center for Translational Neuro- and Behavioral Science, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Adela Della-MarinaKlinik für Kinderheilkunde 1, Abteilung für Neuropädiatrie, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Heike KölbelKlinik für Kinderheilkunde 1, Abteilung für Neuropädiatrie, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Hildegard LaxInstitut für Medizinische Informatik, Biometrie und Epidemiologie, Hufelandstraße 55, 45122, Essen, Deutschland.
Michael NonnemacherInstitut für Medizinische Informatik, Biometrie und Epidemiologie, Hufelandstraße 55, 45122, Essen, Deutschland.
Christoph KleinschnitzKlinik für Neurologie und Center for Translational Neuro- and Behavioral Science, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Ulrike Schara-SchmidtKlinik für Kinderheilkunde 1, Abteilung für Neuropädiatrie, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Tim HagenackerKlinik für Neurologie und Center for Translational Neuro- and Behavioral Science, Universitätsmedizin Essen, Hufelandstraße 55, 45147, Essen, Deutschland. tim.hagenacker@uk-essen.de.
Zentrum für Kinderheilkunde · DEInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvances in healthcare systems with new therapeutic options improve the life expectancy of patients with neuromuscular diseases. With this, a shift in the phenotype of the diseases from the neuromuscular system towards other organs is more frequently observed, requiring closer interdisciplinary cooperation in caring for these young adults. Therefore, the transition to the adult caring system is nowadays a multilayered transfer with the need for complex care of these patients.

objectiveHow can the transitional process be efficiently structured to combine the therapeutic effort of each specialist discipline involved and improve the healthcare process and quality of life in young adults with neuromuscular diseases? MATERIAL AND

methodThe Departments of Neuropediatrics and Neurology of the University Medicine Essen established the Essen transition model for a structured transitional process. A concept of care was developed for the late onset Pompe's disease, Duchenne muscular dystrophy and juvenile myasthenia gravis representatively for neuromuscular diseases. It consists of four components: 1) In a standardized operational procedure (SOP), general processes, clinical diagnostic steps and guidance of treatment between the two departments are harmonized and specified. 2) The young adults and their relatives are seen in a joint consultation of both disciplines allowing a comprehensive handover for healthcare professionals. 3) In a quarterly meeting, transition conference representatives from the different specialized disciplines from pediatric and adult medicine get together for a case-related interdisciplinary exchange. 4) An interdepartmental transitional database was created to integrate all diagnostic results and parameters as a common information platform and data basis.

conclusionThe Essen transition model aims to close a gap in the transition of patients with neuromuscular diseases and improve healthcare in these patients with their complex needs.

Indexed as

Myasthenia GravisNeurologyNeuromuscular DiseasesDelivery of Health CareHumansQuality of LifeDuchenne DystrophyInterdisciplinarityJuvenile Myasthenia GravisLate onset Pompe´s DiseaseNeuromuscular Disorders

Identifiers

PMID35254466
PMCPMC9898325
OpenAlexW4220989522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.